This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Pancreatic Adenocarcinoma Gene Environment Risk Study (PAGER)

This study is currently recruiting participants.
See Contacts and Locations
Verified July 2017 by Randall Brand, University of Pittsburgh
Information provided by (Responsible Party):
Randall Brand, University of Pittsburgh Identifier:
First received: June 1, 2009
Last updated: July 21, 2017
Last verified: July 2017
After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.

Pancreatic Cancer

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Prospective
Official Title: The Pancreatic Adenocarcinoma Gene Environment Risk Study -A Prospective Cohort Study of Patients at Risk or Having Pancreatic Disease

Resource links provided by NLM:

Further study details as provided by Randall Brand, University of Pittsburgh:

Primary Outcome Measures:
  • The data will be used in cohort association studies. Endpoints will depend on the number of patients in the study and the number of markers that are being evaluated. [ Time Frame: 10 years ]

Biospecimen Retention:   Samples With DNA
Blood and urine specimens

Estimated Enrollment: 10000
Study Start Date: January 2004
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
Pancreatic Cancer
individuals who have been diagnosed with pancreatic cancer
individuals who have not been diagnosed with pancreatic cancer


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Participants who are diagnosed with pancreatic cancer, who are undergoing a procedure to evaluate their pancreas, and who have a family history of pancreatic cancer are recruited during appointments at the University of Pittsburgh Medical Center (e.g. Pancreas Specialty Care Center, GI laboratory, Hereditary GI Program)

Inclusion Criteria:

  • Histologically confirmed or CT confirmed diagnosis of pancreatic adenocarcinoma
  • Subjects with abnormal imaging study (CT, MRI, MRCP, EUS)
  • Control subjects with a clinical diagnosis of a pancreas, liver, or intestinal condition
  • Control subject with acute pancreatitis
  • Control subject with chronic pancreatitis
  • Control subject with biliary obstruction
  • Control subject with pancreatic cyst
  • Member of a high risk family (≥ 1 close relative with pancreatic cancer)
  • Healthy control (without any of the above conditions)

Exclusion Criteria:

  • Under the age of 18 years
  • Unable to give informed consent
  • Inability to travel to Pittsburgh for in-person enrollment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00912717

Contact: Randall E Brand, MD 412-623-3105
Contact: Beth Dudley, MS, MPH, CGC 412-623-3105

United States, Pennsylvania
University of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Randall E Brand, MD    412-623-3105   
Sponsors and Collaborators
University of Pittsburgh
Principal Investigator: Randall E Brand, MD University of Pittsburgh
  More Information

Responsible Party: Randall Brand, M.D., University of Pittsburgh Identifier: NCT00912717     History of Changes
Other Study ID Numbers: PRO07030072
Study First Received: June 1, 2009
Last Updated: July 21, 2017

Additional relevant MeSH terms:
Pancreatic Diseases
Pancreatic Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Digestive System Neoplasms
Neoplasms by Site
Endocrine Gland Neoplasms
Digestive System Diseases
Endocrine System Diseases processed this record on August 23, 2017